EGFR Resisters
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
EGFR Resisters
Jul 5, 2024, 13:40 |
Blog
Amy C. Moore: It's hard to even conceive of an advocacy world without Ivy Elkins
Amy C. Moore, VP, Global Engagement and Research Partnerships at LUNGevity Foundation, shared a post…
Jun 25, 2024, 14:27 |
Blog
We mourn the loss of our Ivy Elkins
In December 2013, Ivy Elkins was diagnosed at age 47 with EGFR-positive stage 4 lung…
Jun 24, 2024, 02:03 |
Opinion
Jill Feldman: We need a shift in the Adverse Event grading system
Jill Feldman shared a post on X: “Just thinking, I strongly advocate changing the dose…
Jun 20, 2024, 15:51 |
Insight
Jill Feldman: Must-read about the burdens and barriers patients face
Jill Feldman shared a post by Nathan Pennell, Vice Chair of Clinical Research at Cleveland Clinic…
Jun 14, 2024, 05:42 |
Blog
EGFR Resisters and Young Lung Cancer Initiative are hosting a webinar
Young Lung Cancer Initiative shared on X: "Live Event Alert! EGFR Resisters and Young Lung…
Jun 6, 2024, 10:08 |
Societies
Annabelle Gurwitch: ASCO Patient Award this year goes to the amazing Jill Feldman
Annabelle Gurwitch recently shared a post on X: "Holding each other close. The ASCO Patient…
Jun 1, 2024, 12:22 |
Blog
Annabelle Gurwitch: Thanks ASCO for granting me a patient advocate scholarship
Annabelle Gurwitch shared a post by Charu Aggarwal, Leslye M. Heisler Associate Professor of Lung…
May 29, 2024, 04:59 |
Blog
Estela Rodriguez: Patients excluded from most clinical trials does not help us find solutions with Leptomeningeal disease
Estela Rodriguez shared a post by EGFR Resisters on X/Twitter: "Leptomeningeal disease - is one of…
May 9, 2024, 14:30 |
Blog
Jill Feldman: Dosing studies are critical!
Jill Feldman, Co-Founder of EGFR Resisters, shared a post on X: "Dosing studies are critical! OS…
Apr 15, 2024, 13:05 |
Blog
Jill Feldman: A must-attend educational session at ASCO24
Jill Feldman shared a post on X: "Words couldn't be more true - In the era…
Mar 25, 2024, 12:26 |
Blog
Jill Feldman: It is a tremendous honor for the EGFR Resisters to be nominated for the Healio HemOnc Today Patient Voice award among these esteemed organizations
Jill Feldman, Co-Founder of EGFR Resisters, shared a post by Healio on LinkedIn, adding: "It…
Mar 24, 2024, 13:03 |
Career
Jill Feldman Awarded the 2024 ASCO Patient Advocate Award
The American Society of Clinical Oncology (ASCO) has announced Jill Feldman, as the recipient of the 2024 ASCO…
Mar 9, 2024, 19:24 |
Blog
11 posts not to miss from International Women's Day 2024
International Women's Day is celebrated annually on March 8th. Below are featured some of the…
Feb 13, 2024, 18:54 |
Opinion
Jill Feldman: It's the era of patient-centered ‘everything’ and patients are the ONLY ones who can define what that means
Jill Feldman shared Fumiko Ladd Chino's post on X/Twitter, adding: "It's the era of patient-centered ‘everything’…
Feb 10, 2024, 19:00 |
Insight
Jill Feldman: We must try to be ‘precise’ with dosing so people can LIVE better
Jill Feldman shared on X/Twitter: "Thank you, Associated Press for this story on dosing! No…
Jan 26, 2024, 18:13 |
Blog
Jill Feldman: This picture is worth a thousand words!
Jill Feldman recently shared a post on her LinkedIn page: "This picture is worth a…
Jan 13, 2024, 10:04 |
Blog
Nathan A. Pennell: Pralsetinib development outside the US and China also stopped
Nathan A. Pennell, Co-Director of the Cleveland Clinic Lung Cancer Program, shared a post by…
Jan 8, 2024, 14:37 |
Blog
A 32-year-old lung cancer survivor, mother of 2 and oncology nurse practitioner - EGFR Resisters
EGFR Resisters shared a post on X/Twitter: "Meet Caroline, A 32-year-old lung cancer survivor, mother…
Dec 31, 2023, 20:07 |
Blog
Katsuaki Maehara: Patritumab Deruxtecan (HER3-DXd) clinical trial transition
Katsuaki Maehara, Director of Medical Education Colleagues, recently shared a post by EGFR Resisters on X/Twitter,…
Sep 23, 2023, 15:55 |
Positive
100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2023: Part 5
A month ago, OncoDaily began its series on '100 Influential Women in Oncology: Key Opinion…
All:
20
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube